CA3092871A1 - Aav chimeras - Google Patents
Aav chimeras Download PDFInfo
- Publication number
- CA3092871A1 CA3092871A1 CA3092871A CA3092871A CA3092871A1 CA 3092871 A1 CA3092871 A1 CA 3092871A1 CA 3092871 A CA3092871 A CA 3092871A CA 3092871 A CA3092871 A CA 3092871A CA 3092871 A1 CA3092871 A1 CA 3092871A1
- Authority
- CA
- Canada
- Prior art keywords
- serotype
- domains
- aav2
- rep
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/861—Adenoviral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14161—Methods of inactivation or attenuation
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862639466P | 2018-03-06 | 2018-03-06 | |
| US62/639,466 | 2018-03-06 | ||
| PCT/US2019/021048 WO2019173538A1 (en) | 2018-03-06 | 2019-03-06 | Aav chimeras |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3092871A1 true CA3092871A1 (en) | 2019-09-12 |
Family
ID=67846340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3092871A Pending CA3092871A1 (en) | 2018-03-06 | 2019-03-06 | Aav chimeras |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11905524B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3762501A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2021514659A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20200130337A (cg-RX-API-DMAC7.html) |
| CN (1) | CN112166195A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019231711A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3092871A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019173538A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL314171A (en) | 2015-09-28 | 2024-09-01 | Univ Florida | Methods and compositions for antibody-evading virus vectors |
| US11905524B2 (en) | 2018-03-06 | 2024-02-20 | University Of Florida Research Foundation, Incorporated | AAV chimeras |
| CA3095179A1 (en) | 2018-04-03 | 2019-10-10 | Stridebio, Inc. | Antibody-evading virus vectors |
| MX2020010465A (es) | 2018-04-03 | 2021-01-08 | Vectores de virus para direccionamiento a tejidos oftalmicos. | |
| BR112020020266A2 (pt) | 2018-04-03 | 2021-01-19 | Stridebio, Inc. | Vetores de vírus com evasão de anticorpos |
| CN113727992A (zh) | 2019-03-21 | 2021-11-30 | 斯特里迪比奥公司 | 重组腺相关病毒载体 |
| CN114787180A (zh) | 2019-10-17 | 2022-07-22 | 斯特里迪比奥公司 | 用于治疗c型尼曼-匹克病的腺相关病毒载体 |
| MX2022004353A (es) | 2019-10-17 | 2022-07-19 | Casete de transferencia de aav. | |
| US12054738B2 (en) | 2020-07-30 | 2024-08-06 | Shape Therapeutics Inc. | Stable cell lines for inducible production of rAAV virions |
| JP2023542614A (ja) | 2020-08-19 | 2023-10-11 | サレプタ セラピューティクス, インコーポレイテッド | レット症候群の治療のためのアデノ随伴ウイルスベクター |
| WO2024143440A1 (ja) | 2022-12-28 | 2024-07-04 | 富士フイルム株式会社 | アデノ随伴ウイルスの製造方法、およびベクターのセット |
| AU2024223271A1 (en) * | 2023-02-17 | 2025-09-18 | Synplogen Co., Ltd. | Itr-rep gene complex |
| CN116622908B (zh) * | 2023-04-13 | 2024-02-06 | 武汉珈创生物技术股份有限公司 | 快速检测野生型腺相关病毒的引物探针、试剂盒及方法和应用 |
| TW202548023A (zh) * | 2024-03-14 | 2025-12-16 | 美商雅菲納治療公司 | 用於生產重組腺相關病毒的質體系統 |
| US20260022401A1 (en) | 2024-07-22 | 2026-01-22 | Hoffmann-La Roche Inc. | Novel AAV rep ORFs and Rep polypeptides |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001517454A (ja) | 1997-09-19 | 2001-10-09 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 組換えアデノ随伴ウイルスの産生に有用な方法および細胞株 |
| EP1135468B1 (en) * | 1998-11-10 | 2010-01-06 | University Of North Carolina At Chapel Hill | Virus vectors and methods of making and administering the same |
| US6723551B2 (en) | 2001-11-09 | 2004-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Production of adeno-associated virus in insect cells |
| AU2002367943A1 (en) | 2001-12-18 | 2003-12-22 | University Of North Carolina At Chapel Hill | Improved reagents and methods for producing parvoviruses |
| CN1461805A (zh) * | 2002-05-27 | 2003-12-17 | 本元正阳基因技术股份有限公司 | 一组重组单纯疱疹病毒的构建及其用途 |
| CN101724608A (zh) * | 2008-10-10 | 2010-06-09 | 中国疾病预防控制中心病毒病预防控制所 | 用于重组aav2/8病毒载体生产的重组i型单纯疱疹病毒及其用途 |
| US9169494B2 (en) * | 2010-01-12 | 2015-10-27 | The University Of North Carolina At Chapel Hill | Restrictive inverted terminal repeats for viral vectors |
| WO2017100674A1 (en) * | 2015-12-11 | 2017-06-15 | The Trustees Of The University Of Pennsylvania | Scalable purification method for aav1 |
| US11905524B2 (en) | 2018-03-06 | 2024-02-20 | University Of Florida Research Foundation, Incorporated | AAV chimeras |
-
2019
- 2019-03-06 US US16/978,657 patent/US11905524B2/en active Active
- 2019-03-06 CA CA3092871A patent/CA3092871A1/en active Pending
- 2019-03-06 AU AU2019231711A patent/AU2019231711A1/en not_active Abandoned
- 2019-03-06 EP EP19764877.7A patent/EP3762501A4/en not_active Withdrawn
- 2019-03-06 WO PCT/US2019/021048 patent/WO2019173538A1/en not_active Ceased
- 2019-03-06 CN CN201980027191.1A patent/CN112166195A/zh active Pending
- 2019-03-06 KR KR1020207027922A patent/KR20200130337A/ko not_active Ceased
- 2019-03-06 JP JP2020546347A patent/JP2021514659A/ja active Pending
-
2023
- 2023-01-05 US US18/150,430 patent/US12163152B2/en active Active
- 2023-10-10 JP JP2023175237A patent/JP2023171525A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3762501A4 (en) | 2022-03-09 |
| US20200407753A1 (en) | 2020-12-31 |
| AU2019231711A1 (en) | 2020-09-24 |
| US12163152B2 (en) | 2024-12-10 |
| WO2019173538A1 (en) | 2019-09-12 |
| US20230399658A1 (en) | 2023-12-14 |
| JP2023171525A (ja) | 2023-12-01 |
| CN112166195A (zh) | 2021-01-01 |
| KR20200130337A (ko) | 2020-11-18 |
| US11905524B2 (en) | 2024-02-20 |
| EP3762501A1 (en) | 2021-01-13 |
| JP2021514659A (ja) | 2021-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12163152B2 (en) | AAV chimeras | |
| US11542478B2 (en) | Restrictive inverted terminal repeats for viral vectors | |
| CN112194706B (zh) | 腺相关病毒突变体及其应用 | |
| EP2403867B1 (en) | Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essential consisting of vp3 | |
| US9441206B2 (en) | Cell line for production of adeno-associated virus | |
| JP7703535B2 (ja) | 組み換えaav生産のための新規の組成物および方法 | |
| CN112041442A (zh) | 用于逃避抗体的病毒载体的方法和组合物 | |
| JP2026076163A (ja) | 植物毛状根からの組換えウイルスベクターの生産 | |
| CN116041443A (zh) | 腺相关病毒突变体及其应用 | |
| CN114150021A (zh) | 一种包含重叠开放阅读框的基因的表达盒及其在昆虫细胞中的应用 | |
| WO2003104392A2 (en) | Improved reagents and methods for producing parvoviruses | |
| CN115850392B (zh) | 衣壳蛋白融合细胞穿膜肽的腺相关病毒突变体及其应用 | |
| CN115925819A (zh) | 腺相关病毒突变体及其应用 | |
| US20210292373A1 (en) | Aav vp1u chimeras | |
| TW202417619A (zh) | 生產重組 aav 顆粒之方法 | |
| US20260022401A1 (en) | Novel AAV rep ORFs and Rep polypeptides | |
| EP4627094A1 (en) | Adeno-associated virus production platform | |
| WO2024130163A1 (en) | Methods for manufacturing viruses and viral particles | |
| US20240026309A1 (en) | Cell lines for production of adeno-associated virus | |
| CN119569833A (zh) | 靶向骨骼肌的aav衣壳蛋白变体及其用途 | |
| Cho et al. | Improved Production Efficiencies of Various Adeno-Associated Virus (AAV) Serotypes and a Novel Universal AAV Titration Method | |
| CN110938654A (zh) | 一种细胞转染试剂及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220920 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20250513 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250904 |
|
| B12 | Application deemed to be withdrawn, abandoned or lapsed |
Free format text: ST27 STATUS EVENT CODE: N-6-6-B10-B12-B303 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO AN EXAMINER'S REQUISITION Effective date: 20250915 |
|
| U13 | Renewal or maintenance fee not paid |
Free format text: ST27 STATUS EVENT CODE: N-2-6-U10-U13-U300 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO MAINTENANCE FEE NOTICE Effective date: 20251104 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260102 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260417 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260708 |